| Financial Year |
March 31 2023 |
| Monetary Funds |
9,684,696,799.31 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
10,291,017,419.21 |
| Advances to Suppliers |
1,286,957,105.67 |
| Other Receivables |
881,162,191.57 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
6,143,756.63 |
| Inventories |
10,139,994,620.47 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
952,981,908.33 |
| Other Current Assets |
1,684,111,135.59 |
| Total Current Assets |
37,272,873,485.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
495,316,159.42 |
| Investment Properties |
-- |
| Fixed Assetes |
11,382,504,256.72 |
| Under-construction Projects |
5,953,478,785.75 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,585,100,396.97 |
| R&D expenses |
363,132,420.71 |
| Goodwill |
69,269,162.68 |
| Long-Term Deferred and Prepaid Expenses |
147,365,219.88 |
| Deferred Income Tax Assets |
686,475,653.02 |
| Other Non-Current Assets |
12,339,619,293.13 |
| Sub-Total of Non-Current Assets |
33,982,651,369.12 |
| Total Assets |
71,255,524,854.74 |
| Short-Term Loans |
1,077,261,406.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
7,836,263,824.42 |
| Accounts Payable |
8,907,654,457.90 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
177,985,674.34 |
| Taxes Payable |
181,930,891.55 |
| Interest Payable |
-- |
| Dividend Payable |
2,200,000.00 |
| Other payables |
1,348,535,769.70 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
726,083,038.61 |
| Other Current Liabilities |
748,059,619.49 |
| Sub-Total of Current Liabilities |
29,479,847,103.94 |
| Long-term Loans |
6,624,062,362.49 |
| Bonds Payable |
1,365,038,949.89 |
| Long-Term Accounts Payable |
2,437,343,636.55 |
| Special Payable |
-- |
| Estimatied Liabilities |
1,919,510,940.37 |
| Deferred Income Tax Liabilities |
921,617,441.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
13,628,704,198.03 |
| Total Liabilities |
43,108,551,301.97 |
| Paid-In Capital(Or Share Stock) |
2,272,085,706.00 |
| Capital Surplus |
16,968,838,336.49 |
| Surplus Reserve |
740,435,107.35 |
| LESS:Treasury Stock |
90,875,421.69 |
| Undistributed Profits |
7,926,519,691.06 |
| Minority Stockholder's Interest |
248,504,479.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
27,898,469,073.06 |
| Owner's Equity（Stockholder's Equity） |
28,146,973,552.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
71,255,524,854.74 |
